Wednesday, BioMarin Pharmaceutical Inc. (BMRN) reported third-quarter net income of $6.6 million or $0.06 per share, up from $0.8 million or $0.01 per share a year ago. Non-GAAP net income increased to $15.5 million or $0.13 per share from $8.2 million or $0.08 per share.
Revenue increased 11% to $80.8 million for the quarter. Analysts expected earnings of $0.01 per share on revenues of $81.92 million for the quarter.
For fiscal 2009, BioMarin adjusted its revenues revenue guidance to range between $313 million and $327 million from the previous guidance of $311 to $336 million. Analysts currently expect revenues of $324.77 million.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.